You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 284 No. 1, July 5, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Review
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (85)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Cerebrovascular Disease
 •Stroke
 •Quality of Care
 •Evidence-Based Medicine
 •Women's Health
 •Women's Contraception
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ischemic Stroke Risk With Oral Contraceptives

A Meta-analysis

Leslie Allison Gillum, BA; Sai Kumar Mamidipudi, MBBS(India); S. Claiborne Johnston, MD, MPH

JAMA. 2000;284:72-78.

Context  The relationship between ischemic stroke and oral contraceptive (OC) use has been studied for 40 years, but disagreement about an association persists.

Objective  To review available literature to determine whether OC use is associated with increased stroke risk.

Data Sources  Studies published from January 1960 through November 1999 were identified from electronic databases (MEDLINE, BIOSIS, and Dissertation Abstracts Online), Index Medicus, bibliographies of pertinent review articles and pertinent original articles, textbooks, and expert consultation.

Study Selection  From 804 potentially relevant references retrieved, 73 were studies investigating risk of ischemic stroke with OC use. Two reviewers independently applied the following inclusion criteria: more than 10 stroke cases sampled, clear stroke subtype differentiation, concurrent controls included, adequate data included to determine relative risks (RRs) and confidence intervals (CIs), analysis controlled for age, and no later publication of identical data. A third investigator adjudicated disagreements. Sixteen studies met all inclusion criteria and were included in the meta-analysis.

Data Extraction  Two investigators independently extracted data, with disagreements resolved through discussion.

Data Synthesis  The 16 studies were analyzed using random effects modeling. Current OC use was associated with increased risk of ischemic stroke (RR, 2.75; 95% CI, 2.24-3.38). Smaller estrogen dosages were associated with lower risk (P=.01 for trend), but risk was significantly elevated for all dosages. Studies that did not control for smoking (P=.01) and those using hospital-based controls (P<.001) found higher RRs, but no other patient characteristics or elements of study design were important. The summary RR was 1.93 (95% CI, 1.35-2.74) for low-estrogen preparations in population-based studies that controlled for smoking and hypertension. This translates to an additional 4.1 ischemic strokes per 100,000 nonsmoking, normotensive women using low-estrogen OCs, or 1 additional ischemic stroke per year per 24,000 such women. The RR of stroke due to OC use was not different in women who smoked, had migraines, or had hypertension.

Conclusions  Summary results indicate that risk of ischemic stroke is increased in current OC users, even with newer low-estrogen preparations. However, the absolute increase in stroke risk is expected to be small since incidence is very low in this population.


Author Affiliations: Neurovascular Service, Department of Neurology, University of California, San Francisco.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

July 5, 2000
JAMA. 2000;284(1):115-116.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cardiovascular Effects of Physiological and Standard Sex Steroid Replacement Regimens in Premature Ovarian Failure
Langrish et al.
Hypertension 2009;53:805-811.
ABSTRACT | FULL TEXT  

Reproductive History, Oral Contraceptive Use, and the Risk of Ischemic and Hemorrhagic Stoke in a Cohort Study of Middle-Aged Swedish Women
Yang et al.
Stroke 2009;40:1050-1058.
ABSTRACT | FULL TEXT  

Progestogen-Only Contraceptives and the Risk of Stroke: A Meta-Analysis
Chakhtoura et al.
Stroke 2009;40:1059-1062.
ABSTRACT | FULL TEXT  

Stroke in Women: An Evolving Topic
Kurth and Bousser
Stroke 2009;40:1027-1028.
FULL TEXT  

Meta-analysis: Its strengths and limitations
WALKER et al.
Cleveland Clinic Journal of Medicine 2008;75:431-439.
ABSTRACT | FULL TEXT  

Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke
Pruissen et al.
Blood 2008;111:1282-1286.
ABSTRACT | FULL TEXT  

Review Article: Vascular and Metabolic Effects of Sex Steroids: New Insights Into Clinical Trials
Wierman and Kohrt
Reproductive Sciences 2007;14:300-314.
ABSTRACT  

Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives
Pezzini et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:271-276.
ABSTRACT | FULL TEXT  

Hormones and cardiovascular health in women
The ESHRE Capri Workshop Group
Hum Reprod Update 2006;12:483-497.
ABSTRACT | FULL TEXT  

Advancing the Study of Stroke in Women: Summary and Recommendations for Future Research From an NINDS-Sponsored Multidisciplinary Working Group
Bushnell et al.
Stroke 2006;37:2387-2399.
ABSTRACT | FULL TEXT  

Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Goldstein et al.
Circulation 2006;113:e873-e923.
ABSTRACT | FULL TEXT  

Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Goldstein et al.
Stroke 2006;37:1583-1633.
ABSTRACT | FULL TEXT  

Use of oral contraceptives and mortality during 14 years' follow-up of Norwegian women
Graff-Iversen et al.
Scand J Public Health 2006;34:11-16.
ABSTRACT  

Association between the Current Use of Low-Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis
Baillargeon et al.
J. Clin. Endocrinol. Metab. 2005;90:3863-3870.
ABSTRACT | FULL TEXT  

Migraine and ischaemic stroke
Thomas
BMJ 2005;330:54-55.
FULL TEXT  

Risk of Stroke in Women Exposed to Low-Dose Oral Contraceptives: A Critical Evaluation of the Evidence
Chan et al.
Arch Intern Med 2004;164:741-747.
ABSTRACT | FULL TEXT  

Ischemic Stroke Risk in Oral Contraceptive Users * Response
Ciccone et al.
Stroke 2003;34 :e231-e231.
FULL TEXT  

Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats
Stier et al.
Am. J. Physiol. Endocrinol. Metab. 2003;285:E232-E239.
ABSTRACT | FULL TEXT  

Risk of Ischemic Stroke Among Users of the Oral Contraceptive Pill: The Melbourne Risk Factor Study (MERFS) Group
Siritho et al.
Stroke 2003;34:1575-1580.
ABSTRACT | FULL TEXT  

Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women: The Women's Health Initiative: A Randomized Trial
Wassertheil-Smoller et al.
JAMA 2003;289:2673-2684.
ABSTRACT | FULL TEXT  

Prescribing Oral Contraceptives for Women Older Than 35 Years of Age
Seibert et al.
ANN INTERN MED 2003;138:54-64.
ABSTRACT | FULL TEXT  

Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women
Angeja et al.
J Am Coll Cardiol 2001;38:1297-1301.
ABSTRACT | FULL TEXT  

The third generation pill controversy (""continued"")
Drife
BMJ 2001;323:119-120.
FULL TEXT  

Review: current oral contraceptive use increases the risk for ischaemic stroke
Douketis
Evid. Based Med. 2001;6:60-60.
FULL TEXT  

Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association
Goldstein et al.
Circulation 2001;103:163-182.
FULL TEXT  

Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association
Goldstein et al.
Stroke 2001;32:280-299.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.